Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nektar Therapeutics - Common Stock (NQ:NKTR)

0.7495 -0.0469 (-5.89%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,453,141
Open 0.7930
Bid (Size) 0.7504 (1)
Ask (Size) 0.7930 (5)
Prev. Close 0.7964
Today's Range 0.7401 - 0.8297
52wk Range 0.4320 - 1.710
Shares Outstanding 183,801,441
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Scheduled For March 12, 2025
Via Benzinga
Top movers in Friday's after hours session
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill

Performance

YTD
-22.0%
-22.0%
1 Month
-0.8%
-0.8%
3 Month
-11.3%
-11.3%
6 Month
-31.2%
-31.2%
1 Year
-50.0%
-50.0%

More News

Read More
Sweet Nektar?
Via Talk Markets
Nektar Therapeutics Earnings Preview
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Nektar Therapeutics's Earnings: A Preview
Via Benzinga
Assessing Nektar Therapeutics: Insights From 5 Financial Analysts
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Assessing Nektar Therapeutics: Insights From 4 Financial Analysts
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Recap: Nektar Therapeutics Q3 Earnings
Via Benzinga
A Preview Of Nektar Therapeutics's Earnings
Via Benzinga
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential
Via Benzinga
10 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
NKTR Stock Earnings: Nektar Therapeutics Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
NKTR Stock Earnings: Nektar Therapeutics Meets EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Biotech's Lawsuit With Eli Lilly Might Catalyze Stock
Via Talk Markets
Topics Lawsuit
Exposures Financial Legal
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Earnings Scheduled For March 4, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
The One-Minute Market Report - Saturday, Aug. 12
Via Talk Markets
Topics ETFs

Frequently Asked Questions

Is Nektar Therapeutics - Common Stock publicly traded?
Yes, Nektar Therapeutics - Common Stock is publicly traded.
What exchange does Nektar Therapeutics - Common Stock trade on?
Nektar Therapeutics - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nektar Therapeutics - Common Stock?
The ticker symbol for Nektar Therapeutics - Common Stock is NKTR on the Nasdaq Stock Market
What is the current price of Nektar Therapeutics - Common Stock?
The current price of Nektar Therapeutics - Common Stock is 0.7495
When was Nektar Therapeutics - Common Stock last traded?
The last trade of Nektar Therapeutics - Common Stock was at 06/03/25 04:00 PM ET
What is the market capitalization of Nektar Therapeutics - Common Stock?
The market capitalization of Nektar Therapeutics - Common Stock is 137.76M
How many shares of Nektar Therapeutics - Common Stock are outstanding?
Nektar Therapeutics - Common Stock has 138M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.